Skip to main content
Livermore
Livermore
ZHEN

Bollard Group LLC

SEC CIK
0001556218
Latest filing
Aug 12, 2026

CTMX holding history

CytomX Therapeutics, Inc. in every 13F filed by Bollard Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CTMX overviewAll 13F holders of CTMXFull Q2 2026 holdings

Shares (Q1 2025)
0
Sold out in Q1 2025
Value
$0
% of portfolio
0.0%
Quarters held
16
Since Q1 2021
Holdings of CTMX by Bollard Group LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20250$00.0%−712−100.0%Sold outHolders
Q4 2024712$1.00K<0.1%00.0%UnchangedHolders
Q3 2024712$1.00K<0.1%00.0%UnchangedHolders
Q2 2024712$1.00K<0.1%00.0%UnchangedHolders
Q1 2024712$2.00K<0.1%00.0%UnchangedHolders
Q4 2023712$1.00K<0.1%00.0%UnchangedHolders
Q3 2023712$1.00K<0.1%00.0%UnchangedHolders
Q2 2023712$1.00K<0.1%00.0%UnchangedHolders
Q1 2023712$1.00K<0.1%00.0%UnchangedHolders
Q4 2022712$1.00K<0.1%00.0%UnchangedHolders
Q3 2022712$1.00K<0.1%00.0%UnchangedHolders
Q2 2022712$1.00K<0.1%00.0%UnchangedHolders
Q1 2022712$2.00K<0.1%00.0%UnchangedHolders
Q4 2021712$3.00K<0.1%00.0%UnchangedHolders
Q3 2021712$4.00K<0.1%00.0%UnchangedHolders
Q2 2021712$5.00K<0.1%00.0%UnchangedHolders
Q1 2021712$6.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.